Michael Barbella, Managing Editor10.12.23
Ilika and Cirtec Medical have signed a 10-year manufacturing licence to produce the Stereax range of mm-scale batteries at Cirtec's facility in Lowell, Mass.
"We are delighted to be working with Cirtec for the commercialisation of Stereax. Cirtec has a strong track record in the commercialisation of miniature medical devices and we believe this partnership is well-positioned to ensure a high quality, reliable and scalable supply of Stereax batteries to our customers," Ilika CEO Graeme Purdy said.
Ilika will continue to focus on advanced technology development and IP licensing in support of Cirtec's manufacturing and commercialisation activities. This partnership will reinforce Cirtec's ongoing activities in system level miniaturization for the medical device industry.
"We are excited by the prospect of adding Stereax battery technology to our portfolio of medical device solutions. Our 20 years of experience in the design, development and manufacture of medical devices positions Cirtec strongly to work with Ilika to bring its Stereax battery technology to market," Cirtec Medical CEO Brian Highley stated. "We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets."
Ilika specializes in developing solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs.
Cirtec Medical is a vertically integrated, full-service outsource partner providing end-to-end product design, development and manufacturing of Class III and II medical devices and components. Cirtec specializes in advanced product technologies including, neuromodulation, implantable drug delivery, cardiac rhythm management, ventricular assist and minimally invasive systems including TAVR/TMVR. Cirtec has a global footprint with facilities in Brooklyn Park, Minn.; Chandler, Ariz.; Enfield, Conn.; San Jose Calif.; Lowell, Mss.; Coyal Free Zone, Costa Rica; and Birkenfeld, Germany.
"We are delighted to be working with Cirtec for the commercialisation of Stereax. Cirtec has a strong track record in the commercialisation of miniature medical devices and we believe this partnership is well-positioned to ensure a high quality, reliable and scalable supply of Stereax batteries to our customers," Ilika CEO Graeme Purdy said.
Ilika will continue to focus on advanced technology development and IP licensing in support of Cirtec's manufacturing and commercialisation activities. This partnership will reinforce Cirtec's ongoing activities in system level miniaturization for the medical device industry.
"We are excited by the prospect of adding Stereax battery technology to our portfolio of medical device solutions. Our 20 years of experience in the design, development and manufacture of medical devices positions Cirtec strongly to work with Ilika to bring its Stereax battery technology to market," Cirtec Medical CEO Brian Highley stated. "We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets."
Ilika specializes in developing solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs.
Cirtec Medical is a vertically integrated, full-service outsource partner providing end-to-end product design, development and manufacturing of Class III and II medical devices and components. Cirtec specializes in advanced product technologies including, neuromodulation, implantable drug delivery, cardiac rhythm management, ventricular assist and minimally invasive systems including TAVR/TMVR. Cirtec has a global footprint with facilities in Brooklyn Park, Minn.; Chandler, Ariz.; Enfield, Conn.; San Jose Calif.; Lowell, Mss.; Coyal Free Zone, Costa Rica; and Birkenfeld, Germany.